CSIMarket Company Name, Ticker, Customers, else..
 

Vivos Inc  (RDGL)

Vivos Inc's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

RDGL Sales vs. its Competitors Q1 2026


Comparing the current results to its competitors, Vivos Inc reported Revenue increase in the 1 quarter 2026 by 34.84 % year on year.
The revenue growth was below Vivos Inc's competitors' average revenue growth of 37.46 %, achieved in the same quarter.

• List of RDGL Competitors





Revenue Growth Comparisons




Net Income Comparison

Vivos Inc, faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<<  RDGL Stock Performance Comparisons


Vivos Inc's Comment on Competition and Industry Peers


The Company operates in the pharmaceutical and biotechnology sector, focusing on Radiogel™ precision radionuclide therapy. This product competes with established brachytherapy devices in the U.S. and international markets. Key competitors include Oncura (a unit of General Electric Healthcare), C.R. Bard, GT MedTech, Sirtex (manufacturer of SIR-Spheres), and Biocompatibles UK (manufacturer of TheraSphere). The Company currently subcontracts manufacturing to a contract manufacturer in Texas. Previously, manufacturing was subcontracted to IsoTherapeutics, which was acquired by Telix Pharmaceuticals in April 2024. Following this acquisition, the Company has diversified its manufacturing arrangements to reduce dependency and improve supply chain resilience.



  

Overall company Market Share Q1 2026
Contrary to strong revenue growth of 34.84 % in Overall company, Vivos Inc has lost market share within this division.




<<  More on RDGL Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Vivos Inc




Redhill Biopharma Ltd
Share Performance



+19.86%
30 Days
Redhill Biopharma Ltd
Profile

Redhill Biopharma Ltd is a specialty pharmaceutical company focused on improving patient care and developing innovative treatments. Their business model revolves around advancing the research and development of drug candidates in therapeutic areas with unmet medical needs. By seeking partnerships and leveraging their in-house expertise, they aim to bring these potential treatments to market for the benefit of patients worldwide.

More about Redhill Biopharma Ltd 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 0.286 mill. $ -0.429 mill.


Reliability Incorporated
Share Performance



-4.62%
This Quarter
Reliability Incorporated
Profile

Reliability Incorporated operates on a subscription-based model that provides reliable and high-quality services to its customers. By offering a range of maintenance and support solutions, the company guarantees uninterrupted operation of critical systems and equipment for its clients. Reliability Incorporated's business model focuses on building long-term partnerships, prioritizing customer satisfaction, and ensuring consistent and dependable service delivery.

More about Reliability Incorporated's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3.070 mill. $ 20.385 mill. $ -0.451 mill.


Vivos Therapeutics Inc
Share Performance



-93.27%
This Year
Vivos Therapeutics Inc
Profile

Vivos Therapeutics Inc employs a business model that focuses on providing innovative solutions for the treatment of breathing-related sleep disorders.

More about Vivos Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 3.009 mill. $ 21.135 mill. $ -25.627 mill.

Sources: Vivos Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Vivos Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.